Tellgen Showcasing at Medica 2022 with Innovative In Vitro Diagnostics Solutions with Great Echos

0 Comments

From November 14th to 17th, the four-day German MEDICA medical equipment exhibition ended successfully. As the largest and most authoritative medical equipment exhibition, this exhibition attracted about 5,000 exhibitors from various countries, with more than 100,000 visitors worldwide.

In this exhibition, there were a lot of visitors at the booth of Tellgen. Not only did partners visit and have friendly exchanges, but professionals from many countries also showed great interest in our products. Especially the molecular POCT detection system and chemiluminescence solution exhibited by Tellgen have attracted the attention and inquiries of customers and partners from many countries.

Currently, hundreds of POCT detection platforms, such as NuaBox(1A/10B) and AIGS, are installed all over the world, mainly used for the detection of COVID-19, monkeypox, influenza, HPV, and other infectious diseases. The operation is simple, the result is accurate, and customers’ needs in different scenarios are met.

The fully automated chemiluminescence immunoanalyzer TESMI i100, Tellgen chemiluminescence little elf, adopts the acridine ester direct luminescence method, which is small in size, more sensitive and more accurate and is complemented with detection items such as tumor markers, thyroid markers, cardiovascular and inflammatory markers, and hormone, etc., to meet customer needs fully. Currently, reagents and instruments are certified by EU CE IVD, and some products are certified by the FDA and have been registered and sold in many countries around the world. At the same time, many customers have inquired about the TESMI i200, which will be launched in the international market.

Drext DP96, a six-step-all-in-one fully automatic nucleic acid pre-processing machine from barcode scanning, decapping, recapping, diluent, extraction, to PCR setup with a throughput of 4,000 a day, has also attracted the attention of many large laboratories.

For 19 years, Tellgen has always been adhering to the concept of “connecting global technical resources, based on local innovation and creation”, actively participating in major medical equipment exhibitions at home and abroad, learning about the latest medical testing trends, combining with product research and development, providing multi-platform solutions to customers, and commiting to the great cause of healthcare development.

From February 6th to 9th, 2023, Tellgen is inviting to join the 22nd Medlab Middle East Medical Equipment Exhibition in Dubai!

Categories: